Physician

Jose Augusto Ross, MD

According to 2025 Medicare claims, Jose Ross, MD (NPI: 1235119124) practices pathology in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is BAYSHORE PATHOLOGY CONSULTANTS PA (NPI: 1700217460; TIN: 46-4196957) and primary practice location at 33948-1032.

Ross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 8,846 traditional Medicare patients, billed 19,853 HCPCS/CPT codes, and received $841,983 in Medicare payments. The top billing code was 88342 (Special stained specimen slides to examine tissue, initial procedure). 2021 Part D data shows 25 prescription claims across 12 beneficiaries totaling $1,953 in drug costs. Open Payments data shows 1 records totaling $19. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $159,471 to $841,983. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $43,381 to $1,953. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$421K$842K2015 Medicare payment: $159,471 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $178,579 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $258,766 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $295,269 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $384,620 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $412,415 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $571,856 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $702,500 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $702,891 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $841,983 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0802,991$159,471
20161,3203,287$178,579
20171,7034,797$258,766
20181,8895,210$295,269
20192,4576,499$384,620
20203,0386,714$412,415
20213,7139,929$571,856
20224,95314,330$702,500
20235,47113,146$702,891
20248,84619,853$841,983

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$39K$78K2015 Drug cost: $43,381 (USD; Tot_Drug_Cst)2016 Drug cost: $77,506 (USD; Tot_Drug_Cst)2017 Drug cost: $70,382 (USD; Tot_Drug_Cst)2018 Drug cost: $22,322 (USD; Tot_Drug_Cst)2019 Drug cost: $7,991 (USD; Tot_Drug_Cst)2020 Drug cost: $3,493 (USD; Tot_Drug_Cst)2021 Drug cost: $1,953 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015228648$43,381
20162551,210$77,506
20172211,009$70,382
201884322$22,322
201934155$7,991
20201842$3,493
20211225$1,953
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
88342Special stained specimen slides to examine tissue, initial procedure9951,346$74
88313Special stained specimen slides to examine tissue including interpretation and report540625$60
88305Pathology examination of tissue using a microscope, intermediate complexity6,0249,793$38
G0145Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision1,8441,844$26
0753TDigitization of glass microscope slides for level iv surgical pathology616831$0

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$19Myriad Genetic Laboratories, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jose Augusto Ross, MD?

Tedicare shows public-source Medicare data for Jose Augusto Ross, MD (NPI 1235119124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jose Augusto Ross, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jose Augusto Ross, MD?

Jose Augusto Ross, MD is linked to BAYSHORE PATHOLOGY CONSULTANTS PA (billing NPI 1700217460) in the available physician profile data.

Does Jose Augusto Ross, MD have Open Payments data?

Jose Augusto Ross, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.